Indeed, combined blockade of CTLA-4 and PD-1 prolonged survival in a B16 melanoma model (92), and combined PD-L1 and CTLA-4 blockade prolonged disease-free survival in the K7M2 model for metastatic osteosarcoma (93). This evidence concerns the gene CD274 and melanoma.